|
LRCH3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.900100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.190600E-01 |
| Normal-vs-Stage2 |
4.923900E-02 |
| Normal-vs-Stage3 |
2.179000E-04 |
| Normal-vs-Stage4 |
1.975880E-03 |
| Stage1-vs-Stage2 |
1.548770E-01 |
| Stage1-vs-Stage3 |
1.215280E-03 |
| Stage1-vs-Stage4 |
8.484900E-03 |
| Stage2-vs-Stage3 |
3.593200E-01 |
| Stage2-vs-Stage4 |
4.747600E-01 |
| Stage3-vs-Stage4 |
8.676400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.182700E-03 |
| Normal-vs-AfricanAmerican |
1.099610E-01 |
| Normal-vs-Asian |
1.106990E-01 |
| Caucasian-vs-AfricanAmerican |
9.073800E-01 |
| Caucasian-vs-Asian |
5.564300E-02 |
| AfricanAmerican-vs-Asian |
8.911700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.000900E-04 |
| Normal-vs-Female |
3.698200E-01 |
| Male-vs-Female |
7.077600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.713200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.139550E-01 |
| Normal-vs-Age(61-80Yrs) |
1.224690E-03 |
| Normal-vs-Age(81-100Yrs) |
1.720120E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.757000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.411800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.091600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.518100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.364000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.759200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.335200E-03 |
| Normal-vs-Grade 2 |
2.329800E-01 |
| Normal-vs-Grade 3 |
4.363900E-04 |
| Normal-vs-Grade 4 |
3.796900E-04 |
| Grade 1-vs-Grade 2 |
8.464100E-03 |
| Grade 1-vs-Grade 3 |
2.188000E-04 |
| Grade 1-vs-Grade 4 |
2.206300E-04 |
| Grade 2-vs-Grade 3 |
1.042190E-02 |
| Grade 2-vs-Grade 4 |
3.797300E-03 |
| Grade 3-vs-Grade 4 |
2.488600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.408800E-01 |
| Normal-vs-ccB subtype |
2.215900E-03 |
| ccA subtype-vs-ccB subtype |
4.541500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.553900E-02 |
| Normal-vs-N1 |
3.971400E-01 |
| N0-vs-N1 |
8.270400E-01 |
|
|
